The results showed no significant differences in the transcript levels of SOCS5 or SOCS7 between MS patients and the control group, in contrast with other authors who have reported a significant decrease in the expression of SOCS5 in MS patients [28]. The gene discussed is SOCS7; the disease is myeloid sarcoma.